Abalis Pharma AG is active in the development, marketing and licensing of value added pharmaceutical products. The focus is on novel patentable solutions for solid dosage forms based on patent expired API’s aimed at more patient compliance and safety. Abalis Pharma AG offers attractive marketing opportunities to the pharmaceutical industry.

It is located in Switzerland, in the proximity to health care and life science experts, research institutes and universities as well as the international pharmaceutical industry itself.

The management has a longstanding successful international experience in development and marketing of originator as well as generic pharmaceuticals.